Specialty Pharmacy

05/30/2013 - 4:14pm
Rx Response 'ready for action,' group says

An organization set up to provide pharmacy services in the wake of natural disasters is prepared for what experts predict will be a particularly bad hurricane season.

05/30/2013 - 3:08pm
Mo. law expands pharmacy inspection authority

A new law in Missouri allows state regulatory officials to test drugs during inspections.

05/29/2013 - 3:44pm
CARE Pharmacies joins NASP as founding corporate member

The National Association of Specialty Pharmacy announced that CARE Pharmacies has joined the association as a founding corporate member.

05/29/2013 - 2:43pm
Closer collaboration between payers, physicians could reduce cancer care costs, studies find

Healthcare company Cardinal Health has released a series of studies showing ways that it says could reduce the cost of treating cancer.

05/29/2013 - 2:10pm
Biosimilar bill defeated in Texas

Texas has become the latest state to defeat a bill that critics say would limit the reach of knock-off versions of biotech drugs.

05/29/2013 - 1:22pm
GSK buys Switzerland-based Okairos

British drug maker GlaxoSmithKline has acquired Swiss vaccine development company Okairos for $325 million, GSK said Wednesday.

05/29/2013 - 10:37am
NCPA partners with RxWiki to offer digital solutions to community pharmacies and patients

The National Community Pharmacists Association and RxWiki, a leading pharmacy media network, announced a new partnership that will offer digital solutions to more than 23,000 community pharmacies across the country.

05/28/2013 - 11:07am
Armada Health Care achieves full URAC accreditation

Armada Health Care, a specialty pharmacy channel management organization, announced that the organization has been awarded Health Call Center, Health Web Site and Health Content Provider accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

05/23/2013 - 3:02pm
Avella Specialty Pharmacy CEO shortlisted for Ernst & Young award

Ernst & Young has named Avella Specialty Pharmacy founder and CEO John Musil as a finalist for a regional award.

05/23/2013 - 2:55pm
J&J plans slew of regulatory filings through 2017

Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

© 2013 Drug Store News. All Rights Reserved.